. 2022 Aug 25;68(3):399–408. doi: 10.5606/tftrd.2022.8905

Table 2. Visual Analog Scale, HAQ, ODI, FTFD, total PPT, and BDI scores of the patients in the ESWT and CPT groups.

	ESWT group			CPT group			p
		Mean±SD	Median	Min-Max	Mean±SD	Median	p	Min-Max
VAS score
Pre-treatment	65.8±15.7	70a*	20-90	61.9±14.9	60a*	30-100	0.215†
1^st week	31.1±19.8	30b*	0-65	47.5±18.9	50b*	10-70	0.001†
12^th weeks	28.1±18.6	25b*	0-60	47.7±18.5	50b*	10-80	0.001†
P in repeated measurements		0.001‡			0.001‡
HAQ score
Pre-treatment	9.3±7.6	8a*	0-26	9.5±6.5	9.5a*	0-31	0.702†
1^st week	5.3±6.4	3.5b*	0-32	8.4±6.6	7a*	0-25	0.018†
12^th weeks	4.0±6.3	1.5b*	0-30	9.7±7.5	8.5a*	0-29	0.001†
P in repeated measurements		0.001‡			0.655‡
ODI score
Pre-treatment	20.8±10.5	20a*	5-41	22.4±7.8	22a*	8-43	0.466†
1^st week	11.0±9.8	8b*	0-34	19.2±8.3	20a,b*	0-33	0.001†
12^th weeks	9.7±7.8	7b*	0-32	19.7±9.1	19.50b*	2-34	0.001†
P in repeated measurements		0.001‡			0.018‡
FTFD
Pre-treatment	8.8±8.4	7.5a*	0-32	6.1±10.8	0a*	0-40	0.038†
1^st week	5.9±7.3	3.5b*	0-30	4.7±9.5	0a*	0-44	0.100†
12^th weeks	5.0±6.5	2b*	0-28	4.9±10.8	0a*	0-51.9	0.093†
P in repeated measurements		0.001‡			0.278‡
TPPT
Pre-treatment	328.2±164.3	350.3a*	83-667.1	365.9±162.0	400.2a*	82.4-664	0.312†
1^st week	489.0±169.7	494.3b*	189-878.2	375.1±169.7	379.3a*	118.6-855.9	0.006†
12^th weeks	455.8±147.2	445.2b*	228.3-795	338.1±147.1	336.4a*	99.8-708.8	0.002†
P in repeated measurements		0.001‡			0.539‡
BDI score
Pre-treatment	10.3±8.0	8.5a*	0-28	12.9±9.0	10a*	0-33	0.251†
1^st week	6.5±7.8	4.5b*	0-34	7.2±8.6	5.5b*	21-30	0.282†
12^th weeks	4.9±6.9	2b*	0-33	8.9±9.7	6b*	17-34	0.008†
P in repeated measurements		0.001‡			0.001‡
HAQ: Health Assessment Questionnaire; ODI: Oswestry Disability Index; FTFD: Fingertip-to-floor distance; PPT: Pressure pain threshold; BDI: Beck Depression Inventory; ESWT: Extracorporeal shock wave therapy; CPT: Con-ventional physical therapy; SD: Standard deviation; VAS: Visual analog skala; TPPT: Total pressure pain threshold; † Statistical comparison of measurements between groups with the Mann-Whitney U test; ‡ Statistical comparison of repeated measurements within groups with the Friedman test; In repeated measurements within the group (statistical comparison of values pre-treatment, 1^st first week, and 12^th week), the same letters (a and b) indicate that there is no statistically significant difference according to pairwise comparisons with the Bonferroni correction method.